Skip to main content
. Author manuscript; available in PMC: 2021 Apr 1.
Published in final edited form as: Am J Surg Pathol. 2018 Mar;42(3):279–292. doi: 10.1097/PAS.0000000000001000

FIGURE 6.

FIGURE 6.

Immunohistochemistry (A-F). (A) PAX8: diffuse nuclear positivity. (B) S100A1: diffuse nuclear and cytoplasmic positivity. (C) SMARCB1/INI1: complete loss in tumor cells (internal control shows positive staining). (D) OCT3/4: nuclear positivity. (A-D: RMC) (E) FH: complete loss in tumor cells (internal control shows positive staining). (F) 2SC: strong and diffuse nucleocytoplasmic positivity (E-F: FH-deficient RCC).